Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.2.3.23 (
GAS
)
957
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
STAT5 interacts with other factors to control transcription, and the mechanism of regulation is of interest as constitutive active STAT5 has been reported in malignancies. Here, LSD1 and
HDAC3
were identified as novel STAT5a interacting partners in pro-B cells. Characterization of STAT5a, LSD1 and
HDAC3
target genes by ChIP-seq and RNA-seq revealed gene subsets regulated by independent or combined action of the factors and LSD1/
HDAC3
to play dual role in their activation or repression. Genes bound by STAT5a alone or in combination with weakly associated LSD1 or
HDAC3
were enriched for the canonical STAT5a
GAS
motif, and such binding induced activation or repression. Strong STAT5 binding was seen more frequently in intergenic regions, which might function as distal enhancer elements. Groups of genes bound weaker by STAT5a and stronger by LSD1/
HDAC3
showed an absence of the
GAS
motif, and were differentially regulated based on their genomic binding localization and binding affinities. These genes exhibited increased binding frequency in promoters, and in conjunction with the absence of
GAS
sites, the data indicate a requirement for stabilization by additional factors, which might recruit LSD1/
HDAC3
. Our study describes an interaction network of STAT5a/LSD1/
HDAC3
and a dual function of LSD1/
HDAC3
on STAT5-dependent transcription, defined by protein-protein interactions, genomic binding localization/affinity and motifs.
...
PMID:The dual role of LSD1 and HDAC3 in STAT5-dependent transcription is determined by protein interactions, binding affinities, motifs and genomic positions. 2765 63